Current perspectives on camptothecins in cancer treatment.

por Dancey, J., Eisenhauer, E. A.
Publicado 1996

Reporting practices of pharmacodynamic studies involving invasive research procedures in cancer trials

por Freeman, G A, Kimmelman, J, Dancey, J, Monzon, J G
Publicado 2013

A multicentre phase II study of carboplatin and prolonged oral etoposide in the treatment of cancer of unknown primary site (CUPS).

por Warner, E., Goel, R., Chang, J., Chow, W., Verma, S., Dancey, J., Franssen, E., Dulude, H., Girouard, M., Correia, J., Gallant, G.
Publicado 1998

Phase II study of erlotinib (OSI-774) in patients with metastatic colorectal cancer

por Townsley, C A, Major, P, Siu, L L, Dancey, J, Chen, E, Pond, G R, Nicklee, T, Ho, J, Hedley, D, Tsao, M, Moore, M J, Oza, A M
Publicado 2006

A phase II study of the vitamin D analogue Seocalcitol in patients with inoperable hepatocellular carcinoma

por Dalhoff, K, Dancey, J, Astrup, L, Skovsgaard, T, Hamberg, K J, Lofts, F J, Rosmorduc, O, Erlinger, S, Bach Hansen, J, Steward, W P, Skov, T, Burcharth, F, Evans, T R J
Publicado 2003

A phase II clinical and pharmacodynamic study of temsirolimus in advanced neuroendocrine carcinomas

por Duran, I, Kortmansky, J, Singh, D, Hirte, H, Kocha, W, Goss, G, Le, L, Oza, A, Nicklee, T, Ho, J, Birle, D, Pond, G R, Arboine, D, Dancey, J, Aviel-Ronen, S, Tsao, M-S, Hedley, D, Siu, L L
Publicado 2006